Related Experiment Video
Updated: May 10, 2026
11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
[Analgesic effect of succinate-containing preparations]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|June 15, 2013
Summary
Mexidol demonstrates significant analgesic effects by increasing pain thresholds in rodents. Its pain-relieving action is mediated through NMDA and GABAA receptors in the central nervous system.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Pain perception involves complex neural pathways.
- Identifying novel analgesics with distinct mechanisms is crucial for pain management.
Purpose of the Study:
- To investigate the antinociceptive effects of Mexidol.
- To elucidate the underlying neurochemical mechanisms of Mexidol's analgesic action.
Main Methods:
- Animal models (rabbits and rats) were used to assess pain thresholds via electrical stimulation.
- Pharmacological interventions included administration of Mexidol, NMDA receptor antagonist MK-801, and GABAA receptor antagonists (bicuculline, picrotoxin).
- Electrophysiological recordings were performed on sensorimotor cortex and thalamic neurons in rabbits.
Main Results:
- Mexidol significantly increased pain thresholds in rabbits and rats, unlike cytoflavin and reamberin.
- The analgesic effect of Mexidol was attenuated by MK-801 and bicuculline, indicating involvement of NMDA and GABAA receptors.
- Mexidol inhibited neuronal activity in the sensorimotor cortex and ventral posterior thalamic nucleus, an effect blocked by NMDA and GABAA receptor antagonists.
Conclusions:
- Mexidol possesses significant antinociceptive properties.
- The analgesic effects of Mexidol are mediated through the modulation of NMDA and GABAA receptor complexes.
- Mexidol's action on central nervous system neurons involves the inhibition of ion currents through these receptor systems.
Related Concept Videos
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...